Loading…
H.R. 1406119th CongressIn committeeLatest action Feb 18, 2025Decoded by AI · checked against the record
Official title: Lung Cancer Screening and Prevention Act of 2025
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
HR 1406 would let Medicare's HHS Secretary approve new FDA-cleared lung cancer screening tests beyond low-dose CT scans.
40-second read · 4 questions answered below
This bill would let the HHS Secretary approve additional lung cancer screening tests for Medicare coverage, beyond the currently covered low-dose CT scan, as long as the tests are FDA-cleared or approved. The Secretary would set how often the tests can be used and how much Medicare pays, after consulting medical organizations. It also removes one procedural requirement from the standard preventive services coverage process, while keeping the national coverage determination review in place.
This affects Medicare beneficiaries, especially older adults and those at risk for lung cancer. It also affects doctors, hospitals, and companies that develop screening technologies like blood tests.
The change could expand which screening technologies are eligible for Medicare payment, affecting coverage decisions, testing options, and revenue for test makers and providers.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the President.
Latest action: — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.